Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2012

Tri-Lo-Marzia(Norgestimate-Ethinyl Estradiol)Lupin Limited logoLUPIN.NS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Lupin Limited

$74K

Medicare cost, 2024

Medicare drug plans spent $74,037 on Tri-Lo-Marzia (norgestimate-ethinyl estradiol) in 2024, for 2,707 prescriptions and refills filled by 762 patients. New York accounts for the most spending ($8,310, 11% of the total). It is made by Lupin Limited (LUPIN.NS).

Medicare cost, 2024

$74K

+3.7% from 2023

Prescriptions

2,707

$27.35 per claim

Patients

762

867 prescribers

Total spending, 2024

$74K

$97.16 per patient

Questions and answers

How much does Medicare spend on Tri-Lo-Marzia?

Medicare prescription drug plans paid $74K for Tri-Lo-Marzia in 2024, for 2,707 prescriptions and refills to 762 patients (up 3.7% from 2023). The average cost per claim was $27.35.

Which state spends the most on Tri-Lo-Marzia?

New York had the highest Medicare cost for Tri-Lo-Marzia in 2024: $8,310 for 299 claims, followed by Pennsylvania ($5,609).

Who prescribes Tri-Lo-Marzia the most?

Helene M Koch, obstetrics & gynecology in Bala Cynwyd, PA, had the highest Medicare cost for Tri-Lo-Marzia in 2024: 14 claims costing $533.

Who makes Tri-Lo-Marzia?

Tri-Lo-Marzia is made by Lupin Limited (LUPIN.NS), listed in the Medicare spending data as Lupin Pharmaceu.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Tri-Lo-Marzia was $74K in 2024, after a high of $94K in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Tri-Lo-Marzia, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Helene M Koch Bala Cynwyd, PAObstetrics & Gynecology14Under 11$533
Alisa S Ellison Hinton, WVNurse Practitioner15Under 11$490
Debra S Cannon Yuma, TNNurse Practitioner21Under 11$330
Theresa F Rattazzi Monroe, NYNurse Practitioner12Under 11$310
Bozena W Bitner North Arlington, NJEmergency Medicine13Under 11$278
Robert T Byington Lincoln, NEObstetrics & Gynecology11Under 11$220
Cassandra Menelas Far Rockaway, NYNurse Practitioner19Under 11$207
Robert S Thacker Caldwell, IDNurse Practitioner11Under 11$188
Pooja V Shah Philadelphia, PANurse Practitioner11Under 11$184
Guy A Buonincontro New Lisbon, NJFamily Practice13Under 11$181
Shannon Case North Little Rock, ARObstetrics & Gynecology12Under 11$171
Robert C Lalouche Terre Haute, INObstetrics & Gynecology11Under 11$171
Lee A Boone Marion, KYNurse Practitioner11Under 11$168
David Behar Bethlehem, PAPsychiatry12Under 11$166
Matthew R Odom Gainesville, FLEmergency Medicine13Under 11$148
Brian K Blackwell New Canton, VAInternal Medicine14Under 11$141
Jennifer A Nickell Sikeston, MOObstetrics & Gynecology13Under 11$141
Barbrette A Clayborn West Point, MSObstetrics & Gynecology13Under 11$140
Brent C Nimeth Mount Vernon, OHFamily Practice12Under 11$134
Sarah Swafford Cohutta, GAPsychiatry12Under 11$134
Kristen M Mueller Mason, OHNurse Practitioner12Under 11$127
Adam C Major Clearwater, FLNurse Practitioner13Under 11$123
Jason D Richey Charleston, ARFamily Practice11Under 11$121
Stanford A Owen Gulfport, MSInternal Medicine12Under 11$121
Jennifer M Thomas Dennison, OHNurse Practitioner12Under 11$114

Prescriber data by year

YearPrescribersClaimsPatientsCost
20226961,841625$62K
20236141,723536$71K
20248672,707762$74K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Lupin PharmaceuLUPIN.NS logoLUPIN.NS2,707$74K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
3
RxNorm concept IDs
1305757, 578732, 748797, 749155, 749156
Application numbers
ANDA200541

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube